S. Miao - Chemocentryx Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Diabetes - clinical

F. Guebre-Egziabher, T. C. Alves, R. J. Perry, Y. Rahimi, S. K. Majumdar, S. Ioja, N. Kumashiro, M. Kahn, D. Zhang, R. Kibbey,G. I. Shulman, Y.-Y. Chau,L.-C. Lee, C.-T. Lee,J.-B. Chen, W.-C. Lee, C.-H. Chiu,E. Ishimura,K. Mori, H. Wanibuchi, M. Inaba,S. Nakatani,P. Bekker,T. Charvat,S. Miao,D. Dairaghi, L. Lohr,T. Sullivan, L. Seitz,Z. Miao,J. Powers,J. Jaen,T. Schall,T. Idorn,F. Knop,J. Holst,M. Hornum,B. Feldt-Rasmussen,D. Cucchiari,E. Merizzoli,M. Podesta, A. Calvetta, C. Angelini,S. Badalamenti

Nephrology Dialysis Transplantation（2013）

引用1浏览0引用

OP0203 Orally-administered CCR1 Antagonist CCX354-C in a Phase 2 Rheumatoid Arthritis Study:

P. P. Tak,A. Balanescu,V. Tseluyko,S. Bojin, E. Drescher,D. Dairaghi,S. Miao, V. Marchesin,J. Jaen,T. J. Schall,P. Bekker

ANNALS OF THE RHEUMATIC DISEASES（2013）

引用0浏览0引用

THE CCR4 CHEMOKINE RECEPTOR ANTAGONIST CCX6239 FOR THE TREATMENT OF ALLERGIC DISEASES

Z. Miao, Y. Wang,M. Leleti,D. Dairaghi,M. Walters,T. Sullivan,S. Miao,T. Schall,J. Jaen, J. Powers

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGYno. SUP5 (2013): A108-A109

引用0浏览0引用

CCR2 inhibition improves renal function in diabetic BTBR ob/ob Mice

T. J. Sullivan,Z. Miao,R. Berahovich, B. N. Zhao,L. Ertl,T. Baumgart,A. Krasinski,T. Dang,S. Miao,J. P. Powers,J. C. Jaen,T. J. Schall

DIABETOLOGIA（2012）

引用0浏览0引用

Effizienz Und Sicherheit Eines Neuen Chemokin Rezeptor 2 Antagonist, CCX140-B Bei Patienten Mit Typ 2 Diabetes

M Hanefeld, E Schell,I Gouni-Berthold, M Melichar, I Vesela, D Johnson,S Miao,T Sullivan,J Jaen,P Bekker,T Schall

Diabetologie und Stoffwechsel（2012）

引用23浏览0引用

Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose

D J Dairaghi,P Zhang,Y Wang,L C Seitz,D A Johnson,S Miao,L S Ertl, Y Zeng,J P Powers,A M Pennell,P Bekker,T J Schall,J C Jaen

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 5.0 (2011): 726-734

引用55浏览0WOS引用

Safety and efficacy of oral chemokine receptor 2 antagonist CCX140-B in a phase 2 type 2 diabetes study

M. Hanefeld, E. Schell,I. Gouni-Berthold, M. Melichar, I. Vesela,T. Sullivan,S. Miao,D. Johnson,J. C. Jaen,T. J. Schall,P. Bekker

DIABETOLOGIA（2011）

引用0浏览0引用

Chemokine Receptor 2 Antagonist Ccx140-B In Phase 2 For Type 2 Diabetes

T. Sullivan,S. Miao,R. Berahovich, N. Zhao,S. Ungashe,D. Johnson,P. Bekker, J. Jean,T. J. Schall

DIABETOLOGIA（2010）

引用0浏览0引用

SAR studies on a novel series of human cytomegalovirus primase inhibitors

X Chen,J Adrian,T Cushing,H Dimaio,L Liang,V Mayorga,S Miao,M G Peterson,J P Powers,F Spector,C Stein,M Wright,D Xu,Q Ye,J Jaen

Bioorganic & Medicinal Chemistry Letters（2007）

引用22浏览0WOSEI引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn